These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35693310)

  • 1. Survival Impact of Nephroureterectomy for De Novo Stage IV Nonmetastatic and Metastatic Upper Tract Urothelial Carcinoma.
    Lin WY; Lin MH; Yang YH; Chen WC; Huang CE; Chen MF; Wu CT
    Front Surg; 2022; 9():903123. PubMed ID: 35693310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival Effect of Nephroureterectomy in Metastatic Upper Urinary Tract Urothelial Carcinoma.
    Nazzani S; Preisser F; Mazzone E; Marchioni M; Bandini M; Tian Z; Mistretta FA; Shariat SF; Soulières D; Saad F; Montanari E; Luzzago S; Briganti A; Carmignani L; Karakiewicz PI
    Clin Genitourin Cancer; 2019 Jun; 17(3):e602-e611. PubMed ID: 31005472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival benefit of nephroureterectomy in systemic therapy exposed metastatic upper tract urinary urothelial carcinoma patients.
    Morra S; Incesu RB; Scheipner L; Baudo A; Jannello LMI; Siech C; de Angelis M; Tian Z; Creta M; Califano G; Collà Ruvolo C; Saad F; Shariat SF; Chun FKH; de Cobelli O; Musi G; Briganti A; Tilki D; Ahyai S; Carmignani L; Longo N; Karakiewicz PI
    World J Urol; 2024 May; 42(1):343. PubMed ID: 38775841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephroureterectomy vs. segmental ureterectomy of clinically localized, high-grade, urothelial carcinoma of the ureter: Practice patterns and outcomes.
    Piraino JA; Snow ZA; Edwards DC; Hager S; McGreen BH; Diorio GJ
    Urol Oncol; 2020 Nov; 38(11):851.e1-851.e10. PubMed ID: 32859461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemotherapy after radical nephroureterectomy improves the survival outcome of high-risk upper tract urothelial carcinoma patients with cardiovascular comorbidity.
    Luo Y; Feng B; Wei D; Han Y; Li M; Zhao J; Lin Y; Hou Z; Jiang Y
    Sci Rep; 2020 Oct; 10(1):17674. PubMed ID: 33077839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of BCG for non-muscle invasive bladder cancer following nephroureterectomy for upper tract urothelial carcinoma.
    Massari M; O'Malley P; Benidir T; Su LM; Gao H; Crispen PL
    Urol Oncol; 2024 Sep; 42(9):289.e7-289.e12. PubMed ID: 38802293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upper Urinary Tract Urothelial Cancer After Radical Cystectomy for Bladder Cancer: Survival Outcomes After Radical Nephroureterectomy.
    Ślusarczyk A; Zapała P; Piecha T; Zapała Ł; Borkowski T; Radziszewski P
    Ann Surg Oncol; 2024 Mar; 31(3):2144-2153. PubMed ID: 38085392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Consequences of Inadvertent Radical Nephrectomy in the Treatment of Upper Tract Urothelial Carcinoma.
    Al Hussein Al Awamlh B; Shoag JE; Basourakos SP; Lewicki PJ; Posada L; Ma X; Raman JD; Shariat SF; Scherr D
    Urology; 2021 Aug; 154():127-135. PubMed ID: 33766715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of stage II-IV upper-tract urothelial carcinoma and adjuvant chemotherapy for locally advanced cancer.
    Chang YH; Hsiao PJ; Chen GH; Lin CC; Chang CH; Wu HC; Huang CP; Yang CR; Yeh SP
    Oncol Lett; 2019 Jan; 17(1):1341-1348. PubMed ID: 30655904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The comparison of oncologic outcomes between metastatic upper tract urothelial carcinoma and urothelial carcinoma of the bladder after cisplatin-based chemotherapy.
    Hsieh MC; Chiang PH; Rau KM; Chen YY; Su YL; Huang CH
    Urol Oncol; 2015 Nov; 33(11):495.e9-495.e14. PubMed ID: 26254698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative Chemotherapy on Survival in Patients With Upper Urinary Tract Urothelial Carcinoma Undergoing Nephroureterectomy: A Population-Based Study.
    Zhai TS; Jin L; Feng LM; Zhou Z; Liu X; Liu H; Ma WG; Lu JY; Chen W; Yao XD; Ye L
    Front Oncol; 2020; 10():481. PubMed ID: 32373518
    [No Abstract]   [Full Text] [Related]  

  • 12. Variant histology as a significant predictor of survival after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma.
    Kim JK; Moon KC; Jeong CW; Kwak C; Kim HH; Ku JH
    Urol Oncol; 2017 Jul; 35(7):458.e9-458.e15. PubMed ID: 28347659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and Survival Rates of Contemporary Patients with Invasive Upper Tract Urothelial Carcinoma.
    Collà Ruvolo C; Nocera L; Stolzenbach LF; Wenzel M; Cucchiara V; Tian Z; Shariat SF; Saad F; Longo N; Montorsi F; Briganti A; Mirone V; Karakiewicz PI
    Eur Urol Oncol; 2021 Oct; 4(5):792-801. PubMed ID: 33293235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis of Patients Receiving Chemotherapy for Metastatic Upper Tract Urothelial Carcinoma Compared With Metastatic Urinary Bladder Cancer.
    Adomi S; Fujita K; Kita H; Kuwahara K; Akashi Y; Nishimoto M; Matsumura N; Sugimoto K; Minami T; Nozawa M; Yoshimura K; Tahara H; Hirayama A; Nishioka T; Esa A; Uemura H
    Cancer Diagn Progn; 2023; 3(4):484-490. PubMed ID: 37405216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is preoperative anemia a risk factor for upper tract urothelial carcinoma following radical nephroureterectomy?
    Yeh HC; Chien TM; Wu WJ; Li CC; Li WM; Ke HL; Chou YH; Wang CJ; Huang SP; Li CF; Liang PI; Huang CN
    Urol Oncol; 2016 Aug; 34(8):337.e1-9. PubMed ID: 27133951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Risk-based Approach Simulating Oncological Surveillance After Radical Nephroureterectomy in Patients with Upper Tract Urothelial Carcinoma.
    Shigeta K; Kikuchi E; Abe T; Hagiwara M; Ogihara K; Anno T; Umeda K; Baba Y; Sanjo T; Shojo K; Mikami S; Mizuno R; Oya M
    Eur Urol Oncol; 2020 Dec; 3(6):756-763. PubMed ID: 31395480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Systemic Chemotherapy Plus Radical Nephroureterectomy for Metastatic Upper Tract Urothelial Carcinoma.
    Seisen T; Jindal T; Karabon P; Sood A; Bellmunt J; Rouprêt M; Leow JJ; Vetterlein MW; Sun M; Alanee S; Choueiri TK; Trinh QD; Menon M; Abdollah F
    Eur Urol; 2017 May; 71(5):714-718. PubMed ID: 27912971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of cytoreductive surgery for metastatic upper tract urothelial carcinoma: a Surveillance, Epidemiology and End Results (SEER) study of 508 patients.
    Hu H; Lai S; Ni R; Wang M; Lai C; Ji J; Xu T; Hu H
    Transl Androl Urol; 2024 Jun; 13(6):983-993. PubMed ID: 38983475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perineural Invasion is a Powerful Prognostic Factor for Upper Tract Urothelial Carcinoma Following Radical Nephroureterectomy.
    Lin TW; Lee HY; Yang SF; Li CC; Ke HL; Li WM; Li CY; Tu HP; Wu WJ; Yeh HC
    Ann Surg Oncol; 2022 May; 29(5):3306-3317. PubMed ID: 34994908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laparoscopic versus open nephroureterectomy to treat localized and/or locally advanced upper tract urothelial carcinoma: oncological outcomes from a multicenter study.
    Liu JY; Dai YB; Zhou FJ; Long Z; Li YH; Xie D; Liu B; Tang J; Tan J; Yao K; He LY
    BMC Surg; 2017 Jan; 17(1):8. PubMed ID: 28095848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.